{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:22:20Z","timestamp":1792120940188,"version":"4.4.0"},"reference-count":25,"publisher":"Massachusetts Medical Society","issue":"4","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,1,26]]},"DOI":"10.1056\/nejmoa2209226","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T17:01:00Z","timestamp":1674666060000},"page":"310-318","source":"Crossref","is-referenced-by-count":213,"title":["Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A"],"prefix":"10.1056","volume":"388","author":[{"given":"Annette","family":"von Drygalski","sequence":"first","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Chowdary","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Susen","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Matino","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klamroth","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2595-8541","authenticated-orcid":false,"given":"Angela C.","family":"Weyand","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Jimenez-Yuste","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Poloskey","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Winding","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Willemze","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Knobe","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Oncology, Department of Medicine, University of California, San Diego, San Diego (A.D.); the Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London (P.C.); Michigan State University, East Lansing (R. Kulkarni); Centre Hospitalier Universitaire de Lille, Universit\u00e9 de Lille, Lille (S.S.), and Sanofi, Chilly-Mazarin (K.K.) \u2014 both in France; the Washington Center for Bleeding Disorders and the University of Washington \u2014 both in Seattle (B.A.K.); the Institute of Experimental Hematology and Transfusion Medicine, Universit\u00e4tsklinikum Bonn, Bonn (J.O.), and Vivantes Klinikum im Friedrichshain, Berlin (R. Klamroth) \u2014 both in Germany; the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada (D.M.); the Division of Hematology\u2013Oncology, Department of Pediatrics, University of Michigan, Ann Arbor (A.C.W.); Hospital Universitario La Paz, Aut\u00f3noma University, Madrid (V.J.-Y.); Nara Medical University,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14844"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001311"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2012.01750.x"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02682.x"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15444"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13215"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13862"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-713289"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655957"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02856.x"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006119"},{"key":"e_1_3_5_14_2","first-page":"107","article-title":"A phase 1 sequential pharmacokinetic (PK) evaluation of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa in severe hemophilia A.","volume":"28","author":"Lissitchkov T","year":"2022","unstructured":"Lissitchkov T, Willemze A, Jan C, Zilberstein M, Katragadda S. A phase 1 sequential pharmacokinetic (PK) evaluation of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa in severe hemophilia A. Haemophilia 2022;28:Suppl 3:107-108. abstract.","journal-title":"Haemophilia"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-529974"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12161"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12506"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-630897"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001292"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009197"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002699"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1653759"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2021.03.157"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01798-4"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14078"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15741"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2209226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:00:27Z","timestamp":1749668427000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2209226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,1,26]]}},"alternative-id":["10.1056\/NEJMoa2209226"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2209226","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}